Uxin (NASDAQ:UXIN – Get Free Report) and Bath & Body Works (NYSE:BBWI – Get Free Report) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.
Valuation and Earnings
This table compares Uxin and Bath & Body Works”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Uxin | $463.27 million | 0.38 | -$39.69 million | ($0.28) | -2.89 |
| Bath & Body Works | $7.29 billion | 0.59 | $649.00 million | $3.84 | 5.54 |
Bath & Body Works has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Bath & Body Works, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings for Uxin and Bath & Body Works, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Uxin | 1 | 0 | 1 | 0 | 2.00 |
| Bath & Body Works | 1 | 15 | 4 | 0 | 2.15 |
Uxin presently has a consensus price target of $4.50, indicating a potential upside of 456.24%. Bath & Body Works has a consensus price target of $22.20, indicating a potential upside of 4.26%. Given Uxin’s higher possible upside, equities research analysts plainly believe Uxin is more favorable than Bath & Body Works.
Profitability
This table compares Uxin and Bath & Body Works’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Uxin | -10.10% | N/A | -16.37% |
| Bath & Body Works | 10.83% | -53.48% | 13.40% |
Insider and Institutional Ownership
22.4% of Uxin shares are owned by institutional investors. Comparatively, 95.1% of Bath & Body Works shares are owned by institutional investors. 62.9% of Uxin shares are owned by insiders. Comparatively, 0.3% of Bath & Body Works shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility & Risk
Uxin has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Bath & Body Works has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.
Summary
Bath & Body Works beats Uxin on 11 of the 14 factors compared between the two stocks.
About Uxin
Uxin Limited operates a used-car retail business in China, combining an online platform with physical retail locations. Its platform lets customers browse used vehicles and access information to support their purchasing decisions. The company’s services include vehicle inspection and retail sales, along with support for transactions and delivery. Uxin has also offered financing options to customers as part of the vehicle-purchase process. Founded in 2011, Uxin initially built its business around online used-car services and later expanded into direct retail.
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Receive News & Ratings for Uxin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uxin and related companies with MarketBeat.com's FREE daily email newsletter.
